Cocrystal Pharma, Inc. (COCP)Healthcare | Biotechnology | Bothell, United States | NasdaqCM
1.10 USD
-0.04
(-3.509%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.10 |
Hot Take ↕ | Aug. 22, 2026, 5:41 a.m. EDT
The immediate outlook is bearish due to a relentless multi-year price collapse and severe operational distress. The stock has endured nine consecutive years of negative annual returns, with the entire nine-year window showing a catastrophic -99% cumulative loss, signaling a deep structural deterioration rather than a temporary setback. Fundamentally, the company is bleeding cash aggressively, reporting negative operating margins of -30%, negative free cash flow, and negative returns on both assets and equity. The balance sheet is fragile, with debt-to-equity exceeding 128x and no cash reserves to speak of relative to obligations. While the recent price action shows a minor bounce off the lows, this is insufficient to overcome the overwhelming evidence of a failing business model. Furthermore, there is no dividend income to offset these risks, making this a high-risk speculative vehicle with no margin of safety. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.126844 |
| AutoARIMA | 0.131945 |
| AutoTheta | 0.132516 |
| AutoETS | 0.132576 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 3.47 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.276 |
| Excess Kurtosis | 0.20 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 128.448 |
| Revenue per Share | 0.025 |
| Market Cap | 21,189,520 |
| Forward P/E | -1.90 |
| Beta | 1.43 |
| Website | https://www.cocrystalpharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.24000001 |
| Address1 | 19,805 North Creek Parkway |
| All Time High | 1,440.0 |
| All Time Low | 0.76 |
| Ask | 1.45 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 63,970 |
| Average Daily Volume3 Month | 71,650 |
| Average Volume | 71,650 |
| Average Volume10Days | 63,970 |
| Beta | 1.427 |
| Bid | 0.8496 |
| Bid Size | 2 |
| Book Value | 0.076 |
| City | Bothell |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.1 |
| Current Ratio | 1.237 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.18 |
| Day Low | 1.1 |
| Debt To Equity | 128.448 |
| Display Name | Cocrystal Pharma |
| Dividend Date | 1,516,752,000 |
| Earnings Timestamp End | 1,755,084,600 |
| Earnings Timestamp Start | 1,755,084,600 |
| Ebitda | -10,060,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.024 |
| Enterprise To Revenue | 61.702 |
| Enterprise Value | 20,361,520 |
| Eps Current Year | -0.69 |
| Eps Forward | -0.58 |
| Eps Trailing Twelve Months | -0.75 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.016 |
| Fifty Day Average Change | 0.08399999 |
| Fifty Day Average Change Percent | 0.082677156 |
| Fifty Two Week Change Percent | -24.0 |
| Fifty Two Week High | 2.67 |
| Fifty Two Week High Change | -1.57 |
| Fifty Two Week High Change Percent | -0.58801496 |
| Fifty Two Week Low | 0.76 |
| Fifty Two Week Low Change | 0.34000003 |
| Fifty Two Week Low Change Percent | 0.44736847 |
| Fifty Two Week Range | 0.76 - 2.67 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,329,921,000,000 |
| Float Shares | 11,852,454 |
| Forward Eps | -0.58 |
| Forward P E | -1.8965518 |
| Free Cashflow | -4,318,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 10 |
| Fullday Change | -0.04 |
| Fullday Change Percent | -3.50877 |
| Fullday Price | 1.1 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -5,756,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.65712 |
| Held Percent Institutions | 0.057740003 |
| Implied Shares Outstanding | 19,263,200 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,665,446,400 |
| Last Split Factor | 1:12 |
| Long Business Summary | Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is a phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, an HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was headquartered in Bothell, Washington. |
| Long Name | Cocrystal Pharma, Inc. |
| Market | us_market |
| Market Cap | 21,189,520 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_49062639 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -9,938,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 22,152,680 |
| Number Of Analyst Opinions | 2 |
| Open | 1.18 |
| Operating Cashflow | -7,954,000 |
| Operating Margins | -30.32381 |
| Payout Ratio | 0.0 |
| Phone | 877 262 7123 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.1 |
| Post Market Time | 1,787,947,804 |
| Previous Close | 1.14 |
| Price Eps Current Year | -1.594203 |
| Price Hint | 4 |
| Price To Book | 14.473685 |
| Price To Sales Trailing12 Months | 64.21067 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.11 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.04 |
| Regular Market Change Percent | -3.50877 |
| Regular Market Day High | 1.18 |
| Regular Market Day Low | 1.1 |
| Regular Market Day Range | 1.1 - 1.18 |
| Regular Market Open | 1.18 |
| Regular Market Previous Close | 1.14 |
| Regular Market Price | 1.1 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 28,740 |
| Return On Assets | -0.96072996 |
| Return On Equity | -3.11683 |
| Revenue Per Share | 0.025 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 19,263,200 |
| Shares Percent Shares Out | 0.016 |
| Shares Short | 307,605 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 395,023 |
| Short Name | Cocrystal Pharma, Inc. |
| Short Percent Of Float | 0.0194 |
| Short Ratio | 4.75 |
| Source Interval | 15 |
| State | WA |
| Symbol | COCP |
| Target High Price | 10.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 9.0 |
| Target Median Price | 9.0 |
| Total Cash | 2,169,000 |
| Total Cash Per Share | 0.113 |
| Total Debt | 1,341,000 |
| Total Revenue | 330,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.75 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.0859 |
| Two Hundred Day Average Change | 0.014100075 |
| Two Hundred Day Average Change Percent | 0.01298469 |
| Type Disp | Equity |
| Volume | 28,740 |
| Website | https://www.cocrystalpharma.com |
| Zip | 98,011 |